This study describes the previously uncharacterized ontogeny and regulation of truncal adipose reserves in the profoundly growth hormone (GH)-deficient dwarf (dw/dw) rat. We show that, despite normal proportionate food intake, dw/dw rats develop abdominal leanness and hypoleptinemia (circulating leptin halved in dw/dw males; p<0.05) during puberty. This contrasts with the hyperleptinemia seen in moderately GH-deficient transgenic growth retarded (Tgr) rats (circulating leptin doubled at 6 weeks of age; p<0.05) and in GH-receptor/binding protein (GHR/BP)-null mice (circulating leptin doubled; p<0.05). This lean/hypoleptinemic phenotype was not completely normalized by GH treatment, but dw/dw rats developed abdominal obesity in response to neonatal monosodium glutamate (MSG)-treatment or maintenance on a high-fat diet. Unlike Tgr rats, dw/dw rats did not become obese with age; plasma leptin levels and fat pad weights becoming similar to those in WildType rats.
Introduction
It is well established that growth hormone (GH)-deficiency is usually accompanied by an increase in fat accumulation, whereas conditions of GH excess are normally associated with leanness. However, recent studies have revealed that the relationship between GH status and the degree of adiposity is far from simple. For example, while it is assumed that obesity results from the removal of the lipolytic influence of GH (37), it is also recognised that abdominal obesity results in a secondary reduction in GH secretion (35) . Similarly, while GH replacement in patients with primary GHdeficiency leads to specific depletion of intra-abdominal fat (2, 12) , the administration of GH to treat obesity in GH-replete individuals does not elicit a consistent reduction or redistribution in body fat (31). Some of these apparent contradictions may be explained by the depot-specific sensitivity of adipose tissue to the lipolytic action of GH (19) . The relationship between GH status and adiposity in rodent models of GHdeficiency is similarly complex. In the profoundly GH-deficient lit/lit mouse a significant elevation in total proportionate fat mass (14) is reflected in increased inguinal and retroperitoneal fat, whereas parametrial fat is unaffected (26) .
In addition, analysis of the adiposity profile in GH-receptor-null (GHR/BP (-/-) ) mice has revealed that there is a gender-dependent component in this relationship: fat accretion in GHR/BP (-/-) males being elevated in subcutaneous (subscapular) and retroperitoneal depots, but unchanged in epididymal fat (3, 15) , whereas parametrial fat is decreased in GHR/BP (-/-) females, with no significant effect on inguinal fat mass (18). Given that the lipolytic action of GH is dependent upon the pattern of tissue exposure (10) , it is likely that some of these discrepancies may be related to the disturbance of the underlying pattern of GH secretion in these models. It is surprising, therefore, that relatively little is known about the relationship between GH status and adiposity in rat models of GH-deficiency, a species in which the regulation and activity of the GH axis have been characterized more thoroughly.
The dwarf (dw/dw) rat is a widely used model of profound GH-deficiency (8) , in which an unknown genetic defect leads to a 95% reduction in pituitary GH and a 90% reduction in the amplitude of the spontaneous episodes of GH secretion (27,7).
Although we have previously reported that tibial bone marrow adiposity is increased 3-5-fold in adult dw/dw females (21), we had observed that circulating leptin was profoundly reduced (unpublished data), indicating that truncal adiposity may not be elevated in parallel to that in marrow. Thus, in the present study we have tested the hypothesis that the profound GH-deficiency in dw/dw rats is not accompanied by truncal obesity.
We have investigated the development of visceral and bone marrow adiposity in dw/dw rats, and compared the developing adiposity profile with that in the moderately GH-deficient transgenic growth retarded (Tgr) rat (17). In the Tgr model, the expression of human GH (hGH) in the GH releasing hormone (GHRH) neurons leads to a 70-90% reduction in pituitary GH (17,13) and a 70% reduction in the amplitude of spontaneous GH pulses (17,36). In order to determine whether the differences in adiposity between these two models reflect the degree of GH insufficiency, we have also quantified visceral and bone marrow adiposity in two murine models, in which moderate or complete loss of GH signalling arises from the expression of the GHreceptor antagonist, G119KbGH (in GHA-transgenic mice) (9, 25) , or disruption in the GH-receptor/binding protein gene (GHR/BP (-/-) ) (39), respectively.
We have also extended this study to investigate whether the reduction in proportionate fat mass is due to a reduction in energy intake, and whether the degree of adiposity in dw/dw rats can be restored by GH treatment. In addition, we have investigated whether the adipose depots in dw/dw rats respond appropriately to two developmental manipulations known to cause truncal obesity; neonatal monosodium glutamate (MSG)-treatment and maintenance on a high-fat diet. Preliminary reports of elements of this work have previously been communicated (20,33).
Materials & Methods

Animals
The animal procedures described conformed to the respective institutional and national ethical guidelines for animal experimentation, including those involving genetically modified animals, and were specifically approved by local ethical review.
Homozygous dw/dw rats bred on an Albino Swiss (AS) background, used in studies 3 
Study 1: Transpubertal growth and adiposity profiles in GH-deficient rats
To consider the effects of GH-deficiency on adiposity, 3, 6 and 9 week-old male dw/dw, Tgr and AS littermates were weighed and anesthetized with halothane prior to decapitation. Trunk blood was collected, centrifuged and separated plasma was stored at -20 o C for subsequent determination of plasma leptin and IGF-I concentrations by radioimmunoassay (RIA) and immunoenzymometric assay (IEA) respectively.
Visceral (perirenal and retroperitoneal) and epididymal fat pads were excised and weighed. In addition, the right tibiae were removed for subsequent determination of epiphyseal plate width and quantification of bone marrow adiposity.
Study 2: Adiposity profiles in 1 year-old GH-deficient rats
In order to determine whether the lean phenotype observed in dw/dw rats was maintained with age, cohorts of 1 year-old male AS and Tgr littermates and male dw/dw rats were weighed, concussed and decapitated. Trunk blood was collected and treated as above for subsequent determination of plasma leptin concentration by RIA and visceral fat pads were excised and weighed.
Study 3: Adiposity profiles in female dw/dw rats
In order to determine whether the lean phenotype observed in the male dw/dw rat was gender specific, 6-7 week-old dw/dw female rats along with their respective wild-type controls were weighed, concussed and killed by decapitation. Visceral (perirenal and retroperitoneal) and ovarian fat pads were excised post-mortem and weighed. Right tibiae were removed for subsequent quantification of bone marrow adiposity. 
Study 5: Measurement of food intake in dw/dw rats
In order to determine whether the lean phenotype observed in peripubertal dw/dw rats was due to a reduction in food intake, 14 week-old male AS and dw/dw rats were acclimatized to metabolic cages for 1 week, during which body weight continued to increase. Subsequently, food intake was measured for a further 6 days. 
Plasma hormone analysis
The plasma leptin concentrations were determined by RIA (Linco Research Inc., St.
Charles, MO; Cat.# RL-83K; intra-assay variability, 4.4%; sensitivity, 1 pg/ml) and plasma IGF-I (total) concentrations were determined by IEA (Immunodiagnostic Systems Ltd., Tyne & Wear, UK; Ref # AC-18F1; intra-assay variability, 9.2%; sensitivity, 82ng/ml).
Statistical analysis
All data are expressed as the mean ± SEM (n-values shown in the table and figure legends), with statistical comparisons performed using either Student's t-test or oneway ANOVA with either Bonferroni's selected comparison or Student Newman
Kuel's post-hoc tests, as indicated in the table and figure legends.
Results
Study 1: Transpubertal growth and adiposity profiles in GH-deficient rats
Growth parameters
Between 3 and 9 weeks of age, the body weight of male AS rats increased 6-fold (Table 1) . Although similar at 3 weeks of age, body weights of dw/dw and Tgr rats increased at a lower rate than in AS males (Table 1 ; p<0.001) and in parallel with each other. Over the same period, plasma IGF-I concentration increased 3-fold in AS males, but was profoundly suppressed at all ages in both models of GH-deficiency (Table 1 ; p<0.001), being reduced by 60% in Tgr males and 70% in dw/dw males at 9
weeks. Tibial epiphyseal plate width declined with age in all strains, dw/dw rats having significantly narrower plate widths at 3 and 9 weeks (Table 1 ; p<0.001 vs AS).
Adiposity profile
Abdominal adiposity increased with age in all three strains. Visceral (retroperitoneal and perirenal) adiposity in dw/dw males was less than half that in Tgr rats at all ages ( Fig 1A; p<0.05), and was significantly less than that in AS males at 9 weeks of age ( Fig 1A; p<0.001). A similar comparative profile was observed for proportionate epididymal fat pad weights, except that epididymal fat in dw/dw males became significantly lower than that in AS and Tgr rats at 6 weeks of age (Fig 1B; p<0.01).
In conjunction with this decrease in abdominal adiposity, plasma leptin concentrations in dw/dw males were less than half that in their AS counterparts at all ages, being 60% lower at 9 weeks (Fig 1C; p<0.05). In contrast, plasma leptin concentrations were elevated by 2-3-fold in Tgr rats at 3 and 6 weeks of age (Fig 1C; p<0.01 vs AS littermates), but were similar to that in AS rats at 9 weeks of age.
In AS rats, tibial bone marrow adiposity was more than halved between 3 and 6 weeks of age, but was subsequently increased by more than 3-fold at 9 weeks of age. A similar, though less prominent, pattern was also observed in both Tgr and dw/dw rats ( Fig 1D) . Despite the reduction in abdominal adiposity, bone marrow adiposity was not reduced in dw/dw rats in comparison to AS rats at any age ( Fig 1D, G & I) .
However, marrow adiposity was significantly reduced in 9 week-old Tgr rats (Fig 1D; p<0.01 vs AS), which could be accounted for by a significant decrease in adipocyte number (Fig 1E & H 
Study 2: Adiposity profiles in 1 year-old GH-deficient rats
In order to determine whether this lean phenotype is maintained in dw/dw rats, measurements of body weight and adiposity were made in 1-year old males. In Tgr males, a 16% reduction in body weight (Table 2 ; p<0.001) was accompanied by a 30% increase in proportional visceral fat pad weight (p<0.001) and a 2-fold increase in circulating leptin (p<0.01). In contrast, at 1 year of age dw/dw males were neither lean, nor obese and were normoleptinemic, despite a 35% lower body weight in comparison to AS rats (Table 2 ; p<0.001).
Study 3: Adiposity profiles in female dw/dw rats
Analysis of adiposity profiles in female dw/dw rats in the NIMR colony confirmed that the observed reduction in truncal adiposity in dw/dw rats was neither sex-nor institution-specific. A 39% reduction in body weight in dw/dw females (Table 3; p<0.001) was accompanied by 54% and 42% reductions in proportionate visceral (p<0.001) and ovarian (p<0.001) fat pad weights respectively (Table 3 ). In contrast, tibial marrow adiposity was doubled in dw/dw females (p<0.01), which was attributable to the increase in adipocyte number (p<0.01), adipocyte size being unaltered (Table 3) .
Study 4: Adiposity profiles in murine models of profound and moderate GHresistance GHR/BP (-/-) mice
Deletion of the GHR/BP gene resulted in a 47% reduction in body weight (Table 4; p<0.001), a severe reduction in circulating IGF-1 (39) and a 20% reduction in tibial epiphyseal plate width (p<0.01). Although there was no significant alteration in the proportion of visceral or epididymal fat (Fig 2A & B) , there was a slight increase in the proportion of retroperitoneal fat in male GHR/BP (-/-) mice (separate fat pad data not shown; p<0.05). In contrast, deletion of the GHR/BP gene resulted in a 5-fold elevation in tibial marrow adiposity (Fig 2D; p<0 .001), which resulted from the combination of a 3-fold increase in adipocyte number (Fig 2E; p<0 .05) and a smaller elevation in adipocyte size (Fig 2F; p<0.05). Plasma leptin concentration was almost doubled in GHR/BP (-/-) mice (Fig 2C; p<0 .05).
GH-antagonist transgenic mice
Antagonism of the GH receptor in GHA-transgenic mice resulted in a 20% reduction in body weight (Table 4 ; p<0.001), but without a statistically significant reduction in tibial epiphyseal plate width. This was accompanied by a doubling in the proportion of visceral fat ( Fig. 3A; p<0.05), which was reflected in an increase in both perirenal and retroperitoneal fat (separate fat pad data not shown; p<0.01). The proportion of epididymal fat was not significantly increased ( Fig 3B) . In contrast to the large increase in tibial marrow adiposity in GHR/BP (-/-) mice (Fig 2D) , antagonism of the GH-receptor resulted in only a small increase in tibial marrow fat (Fig 3C; p<0.01), which was solely attributable to the increase in adipocyte size (Fig 3E; p<0.05).
Study 5: Measurement of food intake in dw/dw rats
In order to determine whether the lean phenotype observed in the dw/dw rat was due to a reduction in energy intake, we measured daily food intake in male AS and dw/dw rats for 6 days. When expressed in proportion to body weight, food intake was elevated in dw/dw rats (Table 5 ; p<0.01), but when corrected for body surface area, food intake in dw/dw and AS rats was identical.
Study 6: The effect of GH-treatment on adiposity profiles in male dw/dw rats
In order to determine whether the lean phenotype observed in the dw/dw rat was reversible by GH-treatment, a group of dw/dw males was infused with hGH for 14 days. GH-treatment accelerated body weight gain to that seen in untreated AS males (Fig 4A; p<0.001 vs vehicle-treated dw/dw males). Although proportionate perirenal fat pad weight appeared to change in parallel with body weight (Fig 4B) , none of the means were significantly different. In contrast, neither proportionate epididymal fat pad weight (Fig 4C) , nor plasma leptin concentration ( Fig 4D) were increased by hGH treatment, both remaining significantly lower than that seen in untreated AS males (p<0.01).
Study 7: The effect of neonatal MSG-treatment on adiposity profiles in dw/dw rats
Growth parameters
Neonatal MSG-treatment had no significant effect on body weight ( 
Adiposity profile
Neonatal MSG-treatment more than doubled proportionate visceral fat pad weight (Fig 5A; p<0 .001 vs control) in both male and female dw/dw rats. This was accompanied by a 10-fold increase in plasma leptin concentration (Fig 5B; p<0 .001 (male); p<0.01 (female)).
In tibial bone marrow, adipocyte number was not significantly altered by MSGtreatment in either sex (Fig. 5D) . In females, a significant increase in adipocyte size (Fig 5E; p<0.001) was responsible for the doubling of tibial marrow adiposity ( Fig   5C; p<0.05 ). Male dw/dw rats also displayed a significant increase in adipocyte size (Fig 5E; p<0.001 ), but the doubling of mean tibial marrow adiposity was not statistically significant ( Fig 5C) .
Study 8: The effect of a high-fat diet on adiposity profiles in dw/dw rats
Growth parameters
Maintenance on the high fat-diet for 4 weeks did not produce a significant elevation in final body weight, or average daily weight gain in AS rats, but elicited a significant decrease in plasma IGF-I concentration and tibial epiphyseal plate width (Table 7; p<0.05). On the standard chow diet, dw/dw females continued to gain less weight than their AS counterparts (Table 7 ; p<0.001). Average daily weight gain in dw/dw females was not significantly affected by maintenance on the high-fat diet. When the additional weight gain of fat-fed rats was expressed as a proportion of the weight gain of female rats on standard chow, fat-fed AS rats gained 5.8 ± 4.5%, whereas fat-fed dw/dw females gained 12.5 ± 7.6% (not significantly different; p>0.05). Neither plasma IGF-I concentration nor tibial epiphyseal plate width in dw/dw rats were affected by the increase in dietary fat content (Table 7) .
Adiposity profiles
Maintenance on the high-fat diet for 4 weeks had no significant effect on the parameters of adiposity in AS females (Fig 6) . Proportionate perirenal and ovarian fat pad weights, which, as noted previously (Table 3) , were significantly lower in dw/dw females (Fig 6A,B; p<0.01 (perirenal); p<0.05 (ovarian)), were increased by 4-week exposure to elevated dietary fat (Fig 6A,B; p<0.01 (perirenal); p<0.05 (ovarian)). In contrast to experiment 3 (Table 3) , the parameters of tibial marrow adiposity in dw/dw AS females (Fig 6D-F) . This is likely to be due to the larger age range used in this experiment. Although maintenance on the high-fat diet did not affect marrow fat parameters in AS rats, adipocyte size was elevated in dw/dw rats by 55% (Fig 6F; p<0.05).
The corresponding marrow adiposity in dw/dw females was only significantly higher than that in fat-fed AS females (Fig 6D; p<0. 05), and adipocyte number was unaltered (Fig 6D) . Plasma leptin concentration in AS females was unaffected by maintenance on the high-fat diet ( Fig 6C) . As previously observed in male dw/dw rats (Fig 1) , circulating leptin concentrations were significantly reduced in female dw/dw rats on standard chow (Fig 6C; p<0.01). However, when fed elevated dietary fat, circulating leptin was not significantly different from that in similarly fed AS females (Fig 6C) .
Discussion
Much of our knowledge of the relationship between adiposity and growth hormone status has been derived from the study of rodent models of GH-deficiency. It is surprising, therefore, that despite being an extensively used model of dwarfism, our knowledge about the regulation of adiposity in the profoundly GH-deficient dw/dw rat is confined to its susceptibility to diet-induced obesity (10) and the regulation of marrow fat (21).
We have now addressed this issue, demonstrating that in comparison with other rodent models of GH-deficiency, the dw/dw rat is characterized by the development of a remarkably lean phenotype, which is accompanied by profound hypoleptinemia.
This study of the adiposity profile in dw/dw rats not only confirms a previous assertion that these animals are not obese (10), but demonstrates for the first time that, over the peripubertal period, dw/dw males actually developed proportionately lower abdominal fat reserves, accompanied by a marked hypoleptinemia. This feature was not unique to the Cardiff colony and was not affected by gender; similar reductions in visceral and gonadal fat and plasma leptin concentration being observed in male and female dw/dw rats from the Cardiff and Mill Hill colonies. However, the severity of truncal leanness in the dw/dw rat declined with age, so that in 1 year-old males both proportionate abdominal fat reserves and circulating leptin were normal.
Given the severity of GH-deficiency in the dw/dw model (27,7), this abdominal leanness is surprising, contrasting with the obese/hyperleptinemic phenotype of both the profoundly GH-deficient spontaneous dwarf rat (24), and the moderately GH-deficient Tgr rat. It should be noted here that although hyperleptinemia was not observed in 9 week-old Tgr males in the current study, circulating leptin was highly elevated at 3 and 6 weeks of age and becomes progressively elevated in Tgr rats after 9 weeks of age (13), plasma leptin concentrations being increased more than 2-fold in 1 year-old Tgr males (Study 2; 16). Our direct comparison of the Tgr and dw/dw models suggests that either the regulation of adipose tissue is specifically disrupted in the dw/dw rat or that the relationship between the degree of adiposity and the degree of GH-deficiency (or GH-resistance) maybe non-linear.
To test the latter hypothesis, we examined the adiposity profiles in two mouse models of reduced GH signalling; the GHA-transgenic mouse and the GHR/BP-null mouse.
Our observation that visceral adiposity is doubled in the GHA model of partiallyreduced GH-receptor signalling, but not significantly increased in GHR/BP-null mice, appears to lend support to our hypothesis. However, this may only describe the relationship between GH-deficiency and adiposity in pubertal animals, since retroperitoneal fat in 3-6 month-old GHR/BP (-/-) mice is increased more than in similarly aged GHA-transgenic mice (3). It is also important to note that although the proportions of visceral, epididymal and marrow fat were comparable in the two wild-type mouse strains (Fig 2A, B & D and Fig 3 A-C) , the number and size of the marrow adipocytes were considerably different (Fig 2 E & F and Fig 3 D & E) . Such differences may arise from an underlying differential sensitivity of these strains to the genetic manipulations influencing adiposity (3). However, strain-dependent differences cannot explain the leanness in the dw/dw model, since this and the Tgr rat are both maintained on the same genetic background.
In the context of this hypothesis, it is interesting to note that whilst GH inhibits the differentiation of primary preadipocytes (22), it promotes the differentiation of 3T3-F442A fibroblasts into adipocytes (36). This latter process, which is dependent upon activation of the Stat5 signalling pathway (32), suggests that initial exposure to GH (or possibly prolactin) may be a prerequisite for early adipogenic events that enable the subsequent accumulation of adipose reserves during the peripubertal period. This is supported by our observation that GH treatment in post-pubertal dw/dw rats was unable to restore proportionate epididymal fat weight (data for perirenal fat being less unequivocal) or circulating leptin levels in this model (study 6). Although such a mechanism might account for the absence of obesity in dw/dw rats and GHR/BP-null mice, it does not account for our demonstration that similarly aged dw/dw rats and GHR/BP-null mice do not share a lean/hypoleptinemic phenotype. Taken together, our data do not support the hypothesis that the unusual adiposity pofile in the dw/dw rat is a direct consequence of its profound GH-deficiency.
The degree of GH-deficiency is considered to be important in the regulation of intraabdominal fat, but there is now growing evidence for differential regulation of specific adipose depots (17,18,34). As reported previously (21), the adiposity in the tibial marrow compartment was not regulated in parallel to that in abdominal fat (studies 1 and 3), but the advantage of analysing marrow fat is that it enables ready discrimination between adipocyte hypertrophy (lipid accumulation) and adipocyte hyperplasia. Our data indicate that, over the age range studied, the population of marrow adipocytes in male dw/dw rats appears to change in parallel with that in AS males (Fig 1) . In contrast, the occurrence of elevated marrow fat in female dwarves is almost entirely due to the expansion in adipocyte number (Table 3 ; 21), which we have previously shown to be completely reversible by hGH (but not IGF-I) treatment (21). These findings, coupled with our observation of an increase in the marrow adipocyte population in GHR/BP-null mice (Fig 2) , suggest that the absence of the expected elevation in marrow adiposity in pubertal dw/dw males may be due to retarded preadipocyte differentiation or adipocyte proliferation. Whether a similar mechanism is responsible for the truncal leanness in dw/dw rats remains unclear.
In contrast to the control of differentiation and proliferation, the regulation of adipocyte size in dw/dw rats appears normal, or even exaggerated, lipid being accumulated in response to both neonatal MSG exposure (Fig 5) and high fat-feeding (Fig 6) . These manipulations induce similar responses in the weight of abdominal fat reserves. Our data, which corroborates a previous report that high-fat feeding induces obesity in dw/dw females (10), indicates that dw/dw adipocytes not only remain responsive to lipogenic stimulation, but appear more responsive than adipocytes in GH-replete controls (Fig 6) , However, this raises the possibility that the lean phenotype in dw/dw rats may be the consequence of reduced energy intake. The converse scenario has been proposed to occur in the GHA transgenic mice, viz. that elevated adiposity and circulating leptin may be due in part to a proportionate hyperphagia (3), which does not occur in GHR/BP-null mice (3). Our measurement of food intake, however, does not support this hypothesis, since proportionate food intake was not reduced in dw/dw males, but may in fact have been increased (Study 5).
In summary, this study of the adiposity profile in dw/dw rats has produced evidence of developmental abdominal leanness and hypoleptinemia in the context of profound GH-deficiency. The mechanisms underlying this paradoxical leanness are yet to be established, but do not appear to be the direct result of a reduction in either GH signalling or energy intake. Identification of the genetic defect responsible for the dw/dw phenotype may uncover a novel mechanism contributing to the regulation of adiposity. In addition, given the divergent status of adipose reserves in the dw/dw and Tgr rats, further comparative characterization of these models may also reveal the relative contributions of elevated leptin and reduced circulating GH to the development of the pleiotropic abnormalities associated with GH-deficient dwarfism. ). Statistical comparisons were performed by one-way ANOVA. 
